These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 24742370)

  • 1. Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism.
    Morley JF; Pawlowski SM; Kesari A; Maina I; Pantelyat A; Duda JE
    Parkinsonism Relat Disord; 2014 Jul; 20(7):738-42. PubMed ID: 24742370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of hyposmia and other non-motor symptoms to distinguish between drug-induced parkinsonism and Parkinson's disease.
    Morley JF; Duda JE
    J Parkinsons Dis; 2014; 4(2):169-73. PubMed ID: 24284418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder.
    Postuma RB; Lang AE; Gagnon JF; Pelletier A; Montplaisir JY
    Brain; 2012 Jun; 135(Pt 6):1860-70. PubMed ID: 22561644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug induced parkinsonism: a common cause of parkinsonism in older people.
    Thanvi B; Treadwell S
    Postgrad Med J; 2009 Jun; 85(1004):322-6. PubMed ID: 19528308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is 6 months of neuroleptic withdrawal sufficient to distinguish drug-induced parkinsonism from Parkinson's disease?
    Lim TT; Ahmed A; Itin I; Gostkowski M; Rudolph J; Cooper S; Fernandez HH
    Int J Neurosci; 2013 Mar; 123(3):170-4. PubMed ID: 23078283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced parkinsonism as a risk factor for Parkinson's disease: a historical cohort study in Olmsted County, Minnesota.
    Chabolla DR; Maraganore DM; Ahlskog JE; O'Brien PC; Rocca WA
    Mayo Clin Proc; 1998 Aug; 73(8):724-7. PubMed ID: 9703296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of neuroleptic-induced parkinsonism.
    Hassin-Baer S; Sirota P; Korczyn AD; Treves TA; Epstein B; Shabtai H; Martin T; Litvinjuk Y; Giladi N
    J Neural Transm (Vienna); 2001; 108(11):1299-308. PubMed ID: 11768628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing three screening tools for drug-induced parkinsonism in patients with advanced schizophrenia: a pilot study.
    Blanchet PJ; Normandeau L; Rompré PH
    Schizophr Res; 2012 May; 137(1-3):230-3. PubMed ID: 22309978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetry in clinical features of drug-induced parkinsonism.
    Sethi KD; Zamrini EY
    J Neuropsychiatry Clin Neurosci; 1990; 2(1):64-6. PubMed ID: 1983774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic-induced parkinsonism and Parkinson's disease: differential diagnosis and treatment.
    Hausner RS
    J Clin Psychiatry; 1983 Jan; 44(1):13-6. PubMed ID: 6130081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DAT-SPECT imaging in cases of drug-induced parkinsonism in a specialty movement disorders practice.
    Yomtoob J; Koloms K; Bega D
    Parkinsonism Relat Disord; 2018 Aug; 53():37-41. PubMed ID: 29748111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating drug-induced parkinsonism from Parkinson's disease: an update on non-motor symptoms and investigations.
    Brigo F; Erro R; Marangi A; Bhatia K; Tinazzi M
    Parkinsonism Relat Disord; 2014 Aug; 20(8):808-14. PubMed ID: 24935237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waveform analysis of tremor may help to differentiate Parkinson's disease from drug-induced parkinsonism.
    Jang W; Han J; Park J; Kim JS; Cho JW; Koh SB; Chung SJ; Kim IY; Kim HT
    Physiol Meas; 2013 Mar; 34(3):N15-24. PubMed ID: 23442947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype.
    Munhoz RP; Bertucci Filho D; Teive HA
    Neurol Sci; 2017 Feb; 38(2):319-324. PubMed ID: 27853909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.
    Limousin P; Krack P; Pollak P; Benazzouz A; Ardouin C; Hoffmann D; Benabid AL
    N Engl J Med; 1998 Oct; 339(16):1105-11. PubMed ID: 9770557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnosis of manganese-induced parkinsonism.
    Cersosimo MG; Koller WC
    Neurotoxicology; 2006 May; 27(3):340-6. PubMed ID: 16325915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the early signs of drug induced parkinsonism.
    Arblaster LA; Lakie M; Mutch WJ; Semple M
    J Neurol Neurosurg Psychiatry; 1993 Mar; 56(3):301-3. PubMed ID: 8096240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in motor subtype and risk for incident dementia in Parkinson's disease.
    Alves G; Larsen JP; Emre M; Wentzel-Larsen T; Aarsland D
    Mov Disord; 2006 Aug; 21(8):1123-30. PubMed ID: 16637023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival in Parkinson's disease. Relation with motor and non-motor features.
    de Lau LM; Verbaan D; Marinus J; van Hilten JJ
    Parkinsonism Relat Disord; 2014 Jun; 20(6):613-6. PubMed ID: 24679900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Other causes of parkinsonism.
    Tison F
    Baillieres Clin Neurol; 1997 Apr; 6(1):205-18. PubMed ID: 9426876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.